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ORIGINAL CLINICAL STUDY
Purpose: To compare the measurement of intraocular pressure (IOP) 
of Icare rebound tonometer and Perkins applanation tonometer (PAT) 
during community eye screening and to assess the agreement between 
these 2 instruments. 
Design: A cross-sectional, non-interventional study. 
Methods: The IOP measurements by handheld Icare rebound 
tonometer (Finland) were first performed by a primary care physician. 
Then the IOP was measured using Perkins Mk3 applanation tonometer 
(Haag-Streit, UK) by an ophthalmologist who was masked to previous 
readings from the Icare rebound tonometer. The mean IOP measured 
by each tonometer was compared. Pearson correlation coefficient was 
used to explore the correlation between the IOP measurements of the 2 
instruments. The level of agreement between them was assessed using the 
Bland and Altman method. 
Results: A total of 420 left eyes were examined. The mean age of 
subjects was 38.6 ± 18.2 years. Approximately 67% of subjects were 
female. The mean IOP was 16.3 ± 4.0 mm Hg using Icare and 13.4 ± 2.3 
mm Hg using PAT. Pearson correlation coefficient showed a moderate 
positive correlation between the 2 methods (r = +0.524, P < 0.001). 
Linear regression analysis revealed a slope of 0.28 with R2 of 0.255. The 
mean difference between the 2 methods was 2.90 ± 3.5 mm Hg and the 
sample t-test revealed a statistically significant mean difference from 0 
(P < 0.001). The 95% limits of agreement between the 2 methods were 
between −9.73 and 3.93 mm Hg. 
Conclusions: The handheld Icare rebound tonometer is a reasonably 
acceptable screening tool in community practices. However, Icare 
overestimated IOP with a mean of 2.90 mm Hg higher than the PAT. 
Thus, using Goldmann applanation tonometer as a confirmatory 
measurement tool of IOP is suggested.
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Glaucoma is a leading cause of visual impairment. It has been estimated that 76.0 million of world population will suffer 
from glaucoma by year 2020.1 Intraocular pressure (IOP) is the 
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crucial modifiable risk factor in the management of glaucoma, but 
measuring the true IOP clinically can be challenging as it requires 
direct contact with the eye. Hence, a variety of tonometry devices 
have been developed to measure IOP. In clinic setting, Goldmann 
applanation tonometry is widely accepted as the gold standard 
for IOP measurement. However, the Goldmann applanation 
tonometer (GAT) must be mounted on a slit lamp, making it less 
portable to be used in a community setting. Besides, the device 
requires a trained ophthalmologist/clinician to operate. The 
Perkins applanation tonometer (PAT) is a handheld device that 
works on the same principle as the GAT. Established for over 50 
years, Perkins is synonymous to the ‘gold standard’ in handheld 
applanation tonometers. The PAT yields IOP measurements that 
are closely comparable to GAT.2 
The Icare tonometry uses rebound technology, in which a 
light-weight probe is used to make a momentary contact with the 
central cornea. The IOP is measured using deceleration rate and 
contact time of the probe touching the central cornea. The Icare 
rebound tonometer is used widely in the pediatric and community 
care practices as a screening tool for IOP measurements because 
anesthetic is not needed and the probe touch is barely noticed by 
the patient.
In this study, we aimed to compare the Icare rebound 
tonometer with the reference handheld method (PAT) in a 
community eye screening setting and to assess the agreement 
between these 2 instruments.
METHODS
This was a cross-sectional, non-interventional study. All 
subjects who attended the community eye screening program 
organized by the Eye Department of Faculty of Medicine and 
Health Sciences, Universiti Malaysia Sarawak, Malaysia during 
January 1, 2017 to December 31, 2017 were recruited. Those with 
corneal scar, corneal pathology, active ocular infective disease, 
recent intraocular surgery, and allergy to topical anesthetic 
drop were excluded. This study was approved by the Medical 
Ethics Committee of Faculty of Medicine and Health Sciences, 
Universiti Malaysia Sarawak (03/2017). Informed consent was 
obtained from all recruited subjects.
Relevant demographic data such as age and sex were 
recorded. The IOP measurement by handheld Icare TA01i 
tonometer (Finland) was first performed by a primary care 
physician in a sitting position. Six measurements were done on 
the right eye followed by the left eye without topical anesthesia 
drop. The device discarded the highest and lowest IOP reading 
and displayed the mean of the remaining 4 readings. Disposable 
probe tip was changed for each subject and used in both eyes of 
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